Critical Warnings And Restrictions In Canada

Basic Zetia Information

• INN (International Nonproprietary Name): ezetimibe
• Brand Names Available In Canada (English): Zetia (10 mg oral tablet, bottle, Rx)
• ATC Code: C10AX09 — Lipid modifying agent, cholesterol absorption inhibitor
• Forms & Dosages: Tablet, 10 mg; common packaging 30 or 90 count blisters or bottles
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription only (Rx)

Safety comes first with ezetimibe because it is a prescription-only cholesterol medication in Canada.

Do not start ezetimibe without a prescriber’s assessment and a pharmacist review of your medication profile.

Absolute contraindications include moderate-to-severe hepatic impairment and known hypersensitivity to ezetimibe or any excipient.

• Contraindications: Moderate-to-severe hepatic impairment; known hypersensitivity to ezetimibe or excipients; active liver disease or pregnancy/breastfeeding when combined with a statin.

When ezetimibe is co-prescribed with a statin, liver enzyme monitoring is required because of the potential for elevated transaminases.

Patients must report unexplained muscle pain, tenderness, weakness or dark urine immediately due to the increased risk of myopathy or rhabdomyolysis with combined therapy.

• Monitoring Steps For Pharmacists: check DIN on the package; confirm recent liver function tests (LFTs); confirm pregnancy/breastfeeding status before dispensing.

Before You Take Ezetimibe:

• Have a prescriber assessment and active prescription (Rx).
• Confirm baseline liver function tests and any current statin or fibrate use.
• Tell your pharmacist about pregnancy, breastfeeding or unexplained muscle symptoms.

Key Terms:

• DIN: Drug Identification Number required on Canadian packaging for Rx medicines.
• LFT: Liver Function Test, used to monitor transaminases.
• Rx: Prescription-only medication.

Emergency actions for overdose and storage:

• Overdose Plan: Provide supportive care; there is no specific antidote.
• Storage Reminder: Store at 20–25°C (68–77°F) in a dry place, protected from light.

Q&A — Can I Drive After Taking It In Canada?

Ezetimibe is not known to impair driving in most people.

If you experience fatigue, dizziness or muscle weakness, do not drive or operate machinery until symptoms resolve.

Report such symptoms to your prescriber and follow provincial occupational health guidelines at work.

Usage Basics For Canadians

INN, Common Brand Names And Legal Classification

The international nonproprietary name is ezetimibe and the common Canadian brand is Zetia, available as a 10 mg tablet.

A combination product, Vytorin (ezetimibe plus simvastatin), is also commonly prescribed where both agents are needed.

Health Canada classifies ezetimibe as prescription-only (Rx) and products distributed in Canada must carry a DIN on the packaging.

Bilingual labelling may appear in products sold in Quebec or on federally distributed packaging.

Patients should verify the DIN and brand at dispensing since provincial plans may prefer a generic over brand-name Zetia for coverage.

Pharmacy staff should document any allergies and current lipid-lowering therapies in the patient record before dispensing.

What To Bring To The Pharmacist:

• Photo ID and health card.
• Current medication list including any statin or fibrate.
• Pregnancy or breastfeeding status if applicable.

Canadian Dosing Guide

Standard Regimens And Adjustment Notes

The standard adult dose is 10 mg once daily for primary hyperlipidaemia, mixed hyperlipidaemia, homozygous familial hypercholesterolaemia and sitosterolemia.

Pediatric dosing is 10 mg once daily for patients aged ten years and older.

No routine dose adjustment is needed for elderly patients or for renal impairment in most cases.

Ezetimibe is contraindicated or not recommended in moderate-to-severe hepatic impairment due to increased exposure.

When used with statins, baseline LFTs are recommended and reassessment should be done about four to twelve weeks after initiation or dose changes.

Missed dose instructions: take as soon as remembered unless it is close to the next dose, and do not double the dose.

Baseline Tests Checklist:

• Baseline liver function tests (LFTs) before starting or when adding to a statin.
• Creatine kinase (CK) if the patient reports muscle symptoms.
• Pregnancy test when relevant for people of childbearing potential if combined therapy includes a statin.

Q&A — What If I Miss A Dose Under My Provincial Drug Plan?

Clinically, follow the missed-dose guidance above and do not double doses.

For coverage or refill delays caused by prior-authorization paperwork with provincial plans (e.g., ODB, BC PharmaCare, RAMQ), contact the prescriber or the pharmacy immediately.

Many community chains will provide a short emergency supply while authorizations are processed; keep prescription labels and DIN handy to expedite coverage.

Interaction Chart (Canadian Context)

Food, Drink And Common Drug Interactions

Ezetimibe has relatively low systemic interactions when used alone, but combined therapy changes the risk profile.

Combined use with statins can increase the likelihood of liver enzyme elevations and myopathy compared with monotherapy.

Co-administration with fibrates such as fenofibrate may raise the risk of gallstones and myopathy.

Grapefruit is not known to directly interact with ezetimibe alone, but caution is warranted if a statin in the regimen has a grapefruit interaction.

Excess alcohol should be avoided because it can worsen liver toxicity when combined with lipid-lowering drugs.

Common Canadian-prescribed interacting drugs include atorvastatin, simvastatin and fenofibrate, so reconcile medications at each pharmacy visit.

Use provincial drug databases and Health Canada advisories for the latest interaction alerts and formulary guidance.

User Reports And Trends In Canada

Patient-Reported Outcomes And Community Pharmacy Feedback

Many Canadian patients report good tolerability with ezetimibe, with most side effects being mild.

Common complaints include diarrhoea, abdominal pain, fatigue and occasional arthralgia.

When ezetimibe is combined with a statin, more patients report muscle aches although serious myopathy remains uncommon.

Community pharmacies often see ezetimibe prescribed when statin therapy alone does not reach LDL targets or when statin intolerance is suspected.

The availability of generics after patent expiry has improved accessibility in many provinces.

Top Five Patient Concerns:

• Will it cause liver problems?
• Will I get muscle pain when combined with my statin?
• How quickly will my LDL fall?
• Is it safe long-term?
• Will my provincial plan cover the brand or only the generic?

Pharmacies are encouraged to collect anonymized patient-reported outcome measures and to run short in-pharmacy surveys to monitor local tolerability trends.

Online forums can amplify rare anecdotes and do not substitute for professional medical advice.

Access And Purchase Options

Where Canadians Can Get Ezetimibe And Procurement Tips

A prescription from a family physician or specialist is required for ezetimibe under standard Canadian regulations.

It can be filled at national chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, or at licensed Canadian online pharmacies.

Provincial reimbursement rules and special-authority criteria differ between plans like ODB, BC PharmaCare and RAMQ; check each plan for coverage of brand Zetia versus generics.

Verify the DIN to confirm the exact product and price for formulary coverage.

Checklist For The Pharmacy Visit:

• Prescription and recent LDL lab results.
• Health card and ID.
• Complete medication list including over-the-counter supplements.

In our online pharmacy, zetia is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Avoid international sources that do not meet Canadian import and safety requirements unless an import exception applies.

Mechanism And Pharmacology

Patient-Friendly And Clinical Explanations

Ezetimibe works by blocking intestinal absorption of cholesterol at the brush border of the small intestine.

It targets the NPC1L1 transporter to reduce the amount of cholesterol delivered to the liver, which lowers LDL-C in the bloodstream.

In clinical terms, ezetimibe’s ATC code is C10AX09 and it is classified as a cholesterol absorption inhibitor.

Pharmacokinetics: ezetimibe is given orally as 10 mg once daily and usually requires no renal dose adjustment.

Exposure increases in significant hepatic impairment, which is why it is contraindicated in moderate-to-severe liver disease.

Definitions:

• NPC1L1: Intestinal transporter involved in cholesterol absorption.
• LDL-C: Low-density lipoprotein cholesterol, the primary target for reduction.
• ATC Code: C10AX09, classifying ezetimibe in therapeutic groupings.

Suggested patient phrase to tell a provider: "I take ezetimibe daily to lower my LDL."

Indications And Off-Label Uses In Canada

Health Canada–Approved Uses And Common Off-Label Practices

Approved Health Canada indications include primary hyperlipidaemia, mixed dyslipidaemia, homozygous familial hypercholesterolaemia and sitosterolemia at 10 mg once daily for adults and children aged ten years and older.

Common off-label patterns include use as an adjunct in patients intolerant to higher statin doses and as an add-on when statins alone do not reach LDL goals.

Occasionally ezetimibe is used as a temporary bridge if statins are paused for a surgical procedure or for pregnancy planning, but note statins must be avoided in pregnancy and breastfeeding when combined therapy is present.

Monitoring Required For Each Scenario:

• Approved indications: baseline LFTs and LDL check at 4–12 weeks after initiation or change.
• Off-label adjunct use: specialist guidance recommended and close monitoring of LFTs and muscle symptoms.

Off-label use should be under the guidance of a specialist when possible and documented in the patient record.

Key Clinical Findings

Canadian And International Evidence 2022–2025 And Safety Monitoring

Ezetimibe reliably lowers LDL-C when added to statin therapy and has shown incremental cardiovascular benefit in selected high-risk populations historically demonstrated in trials such as IMPROVE-IT.

Recent meta-analyses from 2022–2025 continue to show modest but meaningful absolute LDL reductions and improved outcomes when ezetimibe is added to statin therapy for high-risk patients.

Health Canada and post-marketing surveillance continue to monitor LFT elevations and muscle adverse events, particularly when ezetimibe is used with statins or fibrates.

Ongoing Safety Monitoring Checklist:

• Baseline LFTs prior to initiation when indicated.
• Follow-up LFTs at 4–12 weeks when combined with statins or if symptoms suggest hepatic injury.
• Symptom-driven CK testing for muscle pain or weakness suggesting myopathy.

Alternatives Matrix

Comparable Medicines With DIN In Canada And Pros/Cons

Alternatives to ezetimibe include statins such as atorvastatin and rosuvastatin, fibrates like fenofibrate, PCSK9 inhibitors (evolocumab, alirocumab) and combination ezetimibe+statin formulations such as Vytorin.

Decision Prompts For Clinicians:

• Consider patient preference for oral versus injectable therapy.
• Check comorbidities such as diabetes or liver disease when choosing agents.
• Review prior intolerance history before re-challenging or combining therapies.

Always verify provincial formularies for DIN-preferred options and coverage rules.

Common Questions From Canadian Patients

Is Ezetimibe Safe Long-Term?

Yes, when used under medical supervision with appropriate monitoring; avoid in moderate-to-severe hepatic impairment.

Will It Replace My Statin?

Often ezetimibe is an adjunct to statin therapy or used when statins are not tolerated, but many patients continue on a statin when possible.

Can Pregnant People Take It?

Statins are contraindicated in pregnancy and breastfeeding; discuss risks with your prescriber and avoid statin combinations in pregnancy planning.

How Fast Will LDL Drop?

LDL reductions are typically seen within weeks, and reassessment is commonly done about four to twelve weeks after starting therapy.

Red-Flag Symptoms Requiring Immediate Contact:

• Severe unexplained muscle pain, weakness or dark urine.
• Signs of liver injury such as jaundice, persistent nausea, or upper abdominal pain.
• Allergic reactions such as rash or swelling.

Keep a medication card listing the DIN and prescriber contact for emergencies.

Definitions:

• Statin-Intolerant: Inability to tolerate multiple statins at therapeutic doses because of adverse effects, usually muscle symptoms.
• LDL Target: The patient-specific LDL cholesterol goal set by the prescriber according to risk factors.

Coverage And Purchase Comparison Table

Provincial/Plan Coverage, Typical Patient Cost And Purchase Steps

The following template reflects common coverage patterns: generics are often preferred on provincial formularies, and prior authorization may be required for brand-name Zetia.

Step-By-Step Checklist For Purchasing:

1. Obtain a valid prescription and recent lab results showing LDL if required.
2. Ask the prescriber to specify a DIN-preferred product if coverage is needed.
3. Present health card and ID at the pharmacy to process benefits.
4. Request a short emergency supply from the pharmacy if prior authorization is pending.

Check national chains’ online price tools and patient assistance programs for cost-savings options.

Registration And Regulation

Health Canada Approval, DIN, Labelling And Post-Market Requirements

Ezetimibe products such as Zetia 10 mg tablet are regulated prescription medicines in Canada and must display a DIN on the label for legal distribution.

Health Canada monitors adverse events post-market and requires manufacturers to submit safety updates; pharmacists are asked to report adverse events to the Canada Vigilance Program.

Verify the DIN, expiry date and lot number at dispensing, and confirm bilingual labelling where applicable.

• DIN: Drug Identification Number required on Canadian labels.
• NOC: Notice of Compliance — use not specified where absent.

Regulatory Checks At Dispensing:

• Confirm DIN is present and matches the prescription.
• Check expiry date and lot number for recalls.
• Document counselling and add to patient record.

Storage And Handling

Household And Pharmacy Storage, Transport And Disposal

Store ezetimibe at 20–25°C (68–77°F) in a dry place and protect from light; refrigeration is not required.

Pharmacies should follow temperature-monitoring SOPs to ensure product integrity during storage and transport.

Patients should keep medication in the original container, out of reach of children and pets.

When travelling across provinces or internationally, carry the original prescription and keep medication in carry-on baggage.

Cold-chain is not applicable for ezetimibe.

Disposal: return unused tablets to the pharmacy take-back program or follow municipal medication disposal guidelines.

Guidelines For Proper Use

Pharmacist Counselling Points And Provincial Recommendations

Use the counselling script below to ensure safe and effective therapy for patients starting ezetimibe.

• Confirm the indication and the expected benefit: additional LDL lowering when diet and statin therapy are insufficient.
• Check recent LFTs and pregnancy status before dispensing and document results.
• Ask about concomitant statin or fibrate use and explain the need for liver monitoring when combined.
• Explain common side effects such as diarrhoea, abdominal pain, fatigue and arthralgia.
• Give missed-dose instructions and reinforce not doubling doses.
• Advise immediate contact for muscle pain, weakness or dark urine.

Documentation Steps For The Pharmacy Record:

• Record DIN, lot number and counselling provided.
• Set a follow-up plan: LDL recheck in 4–12 weeks and LFT monitoring when used with statins.

Patient Take-Home Checklist:

• Medication card with DIN and prescriber contact.
• Lifestyle advice: diet and exercise to complement pharmacotherapy.
• List of red-flag symptoms that require urgent care.

Refer to provincial pharmacy standards and the Health Canada product monograph for full details and legal requirements.

Delivery Across Canada (English)